Clinical Study
PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?
Table 4
Validity of studied markers for preeclampsia in the first and second trimesters.
| Marker | Cutoff | Sensitivity (95% CI) | Specificity % (95% CI) | Positive predictive value % (95% CI) | Negative predictive value % (95% CI) | Surface under curve (95% CI) |
| PAPPA first trimester | ≤1.65 | 60.0 (49.7–69.7) | 78.0 (68.6–85.7) | 73.2 (62.2–82.4) | 66.1 (56.8–74.6) | 0.793 (0.733–0.854) | PP13 first trimester | ≤88.5 | 77.0 (67.5–84.8) | 82.0 (73.1–89.0) | 81.1 (71.7–88.4) | 78.1 (69.0–85.6) | 0.879 (0.833–0.924) | PAPPA second trimester | ≤100.5 | 71.0 () | 71.0 () | 71.0 () | 71.0 () | 0.809 (0.751–0.867) | PP13 second trimester | ≤315.5 | 79.0 (69.7–86.5) | 80.0 (70.5–87.3) | 79.8 (70.5–87.2) | 79.2 (70.0–86.6) | 0.876 (0.829–0.924) |
|
|